Join
Live feed
·
PRReleasevia Quantisnow
Myriad Genetics Inc. logo

Myriad Genetics Showcases Advancements in Precision Medicine with Recent Oncology Portfolio Expansion and New Data Presentations at ASCO 2022

ByQuantisnow·Wall Street's wire, on your screen.
MYGN· Myriad Genetics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYGN (Myriad Genetics Inc.) and more on Quantisnow.